2006
DOI: 10.4065/81.4.545
|View full text |Cite
|
Sign up to set email alerts
|

Variant Angina Associated With Bitter Orange in a Dietary Supplement

Abstract: The Food and Drug Administration has banned the sale of ephedrine-based weight-loss products because of their association with many cardiovascular adverse effects. Bitter orange is now being used as a stimulant in "ephedra-free" weight-loss supplements but was recently implicated in adverse cardiovascular sequelae. To our knowledge, this report describes the first case of variant angina associated with bitter orange in a dietary supplement.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(22 citation statements)
references
References 12 publications
0
22
0
Order By: Relevance
“…Users of commercial weight-loss products should be warned against the use of ephedrinebased products, but even bitter orange, advertised as being "ephedra-free," was reported to induce variant angina. 15 CAS is associated also with marijuana, alcohol, butane, amphetamine, and several over-the-counter, chemotherapy, antimigraine, and antibiotic medications. 16 Perioperative CAS is prevalent in elderly male patients with coronary risk factors; instability of the autonomic nervous system and vascular hyperactivity in these patients are supposed to be the underlying autogenic mechanism of the spasm.…”
Section: Coronary Spasm Under Special Circumstancesmentioning
confidence: 99%
“…Users of commercial weight-loss products should be warned against the use of ephedrinebased products, but even bitter orange, advertised as being "ephedra-free," was reported to induce variant angina. 15 CAS is associated also with marijuana, alcohol, butane, amphetamine, and several over-the-counter, chemotherapy, antimigraine, and antibiotic medications. 16 Perioperative CAS is prevalent in elderly male patients with coronary risk factors; instability of the autonomic nervous system and vascular hyperactivity in these patients are supposed to be the underlying autogenic mechanism of the spasm.…”
Section: Coronary Spasm Under Special Circumstancesmentioning
confidence: 99%
“…Adverse events associated with bitter orange are increased blood pressure and heart rate (Bui, Nguyen, & Ambrose, 2006), myocardial infarction (Nykamp, Fackih, & Compton, 2004), angina (Gange, Madias, Felix-Getzik, Weintraub, & Estes, 2006), and ischemic colitis (Sultan, Spector, & Mitchell, 2006).…”
Section: Bitter Orangementioning
confidence: 99%
“…15 The reported cardiac side effects we identified included tachycardia, tachyarrhythmias, QT prolongation, variant angina, myocardial infarction, cardiac arrest, ventricular fibrillation, syncope, and death. [15][16][17][18][19][20] Most of these side effects occurred when bitter orange was taken with caffeine or ephedrine. Because bitter orange can inhibit the metabolism of drugs by cytochrome P450 3A4 (CYP3A4), taking bitter orange with CYP3A4-metabolized drugs can increase blood levels of those drugs and thus increase the risk of adverse effects.…”
Section: Figurementioning
confidence: 99%